Thomas J. Cumbo - Concepedia

Concepedia

Author

Thomas J. Cumbo

University at Buffalo, State University of New York

Also Known As

T J Cumbo, T. J. Cumbo, T.J. Cumbo, Thomas Cumbo, Thomas J Cumbo, Thomas J. Cumbo

23

Publications

1.1K

Citations

13

H-Index

44

Concepts

All Affiliations

University at Buffalo, State University of New York Millard Fillmore Suburban Hospital

TJ

About

Thomas J. Cumbo is an author at University at Buffalo, State University of New York specializing in medicine, antimicrobial pharmacokinetics, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	869
2	Health Sciences	3	3	303
3	Anesthesia	1	1	33
4	Critical Care Medicine	1	1	147
5	Diagnostic Sciences	1	1	40

Thomas J. Cumbo

×

16

Publications

1.1K

Citations

13

H-Index

	Year	Citations
Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics Joseph A. Paladino, Howard E. Sperry, Julie M. Backes, The American Journal of Medicine Antimicrobial StewardshipAntibioticsOral CiprofloxacinPatient SafetyAbbreviated Course	1991	163
Cefmenoxime Efficacy, Safety, and Pharmacokinetics in Critical Care Patients with Nosocomial Pneumonia Jerome J. Schentag, Donald P. Reitberg, Thomas J. Cumbo The American Journal of Medicine Critical Care MedicineAcute CarePatient SafetyRespiratory InfectionSepsis	1984	147
Gentamicin disposition and tissue accumulation on multiple dosing Jerome J. Schentag, William J. Jusko, John W. Vance, Journal of Pharmacokinetics and Biopharmaceutics MedicineClinical PharmacologyToxicologyPharmacotherapyAntimicrobial Pharmacokinetics	1977	141
Genesis of Methicillin‐Resistant<i>Staphylococcus aureus</i>(MRSA), How Treatment of MRSA Infections Has Selected for Vancomycin‐Resistant<i>Enterococcus faecium,</i>and the Importance of Antibiotic Management and Infection Control Jerome J. Schentag, Judith M. Hyatt, James R. Carr, Clinical Infectious Diseases Enterococcus FaeciumAntibiotic ResistanceDrug ResistanceAntimicrobial StewardshipHealthcare-associated Infection	1998	139
Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory Jerome J. Schentag, Charles H. Ballow, Albert L. Fritz, Diagnostic Microbiology and Infectious Disease Anti-infective AgentsHealth SciencesAntibioticsInfectious Disease DivisionMedicine	1993	124
Accumulation Pharmacokinetics of Tobramycin Jerome J. Schentag, George Lasezkay, Thomas J. Cumbo, Antimicrobial Agents and Chemotherapy UrologyAccumulation PharmacokineticsPharmacokinetic ModelingRenal FunctionMedicine	1978	66
Mathematical Examination of Dual Individualization Principles (II): The Rate of Bacterial Eradication at the Same Area under the Inhibitory Curve is More Rapid for Ciprofloxacin Than for Cefmenoxime Thomas F. Goss, Alan Forrest, David E. Nix, Annals of Pharmacotherapy	1994	60
Comparative tissue accumulation of gentamicin and tobramycin in patients Jerome J. Schentag, George Lasezkay, MartinE. Plaut, Journal of Antimicrobial Chemotherapy Buffalo SearchPathologyPharmacotherapyAntimicrobial ChemotherapyNew York	1978	40
Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. David E. Nix, Mark F. Sands, Charles A. Peloquin, PubMed	1987	37
Prolonged use of a diaphragm and toxic shock syndrome Elizabeth A. Baehler, William P. Dillon, Thomas J. Cumbo, Fertility and Sterility Cardiogenic ShockPneumothoraxOrgan InjuryChest InjuryToxic Shock Syndrome	1982	33

Page 1